Thus TRAIL-induced apoptosis of a fraction of the cancer cell population may be complemented not only by consequent pro-malignant reparatory effects, as we have discussed, but also by further competition-based tumour evolution supported by TRAIL-induced entosis. The gene discussed is TNFSF10; the disease is neoplasm.